Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more
Open Access

Adult neurogenesis in a psychopathological mouse model of trait anxiety and comorbid depression-like behavior: effect of antidepressants

  • Anupam Sah1,
  • Stefano Gaburro1,
  • Claudia Schmuckermair1,
  • Simone B Sartori1,
  • Markus Hauschild1,
  • Ludwig Czibere2,
  • Regina Irschick3,
  • Lars Klimaschewski3,
  • Rainer Landgraf2 and
  • Nicolas Singewald1Email author
BMC Pharmacology20099(Suppl 2):A19

https://doi.org/10.1186/1471-2210-9-S2-A19

Published: 12 November 2009

Background

Evidence has been provided linking neurogenesis to mood disorders. Notably, it has been shown that chronic experimental stress resulting in enhanced depression-like behavior decreases neurogenesis in the dentate gyrus (DG), while antidepressants reverse these stress-induced effects. However, in most studies ''normal'' animals reflecting physiology rather than pathophysiology are used. Therefore, we aimed to investigate neurogenesis in the DG of a mouse model of high-trait anxiety and comorbid depression (HAB), which mimics important features of human psychopathology, and their normal anxiety/depression (NAB) controls.

Methods

BrdU (5-bromo-2'-deoxyuridine) was administered to female HABs and NABs. Mice were sacrificed at 15 and 42 days post BrdU to study cell proliferation and survival respectively. At 42 d the mice were subjected to a forced swim test. Double labelling of BrdU and c-Fos (a marker for neuronal activation) was performed to observe if newborn cells functionally integrated into the DG network. Furthermore, effects of the selective serotonin reuptake inhibitor (SSRI) fluoxetine on depression-like behavior and cell survival were assessed. Finally, gene array studies were conducted in the DG.

Results

Compared to NABs, HAB mice displayed enhanced depression-like behavior in the forced swim test and reduced newborn cell proliferation and survival in the DG. Double-labelling of BrdU and c-Fos revealed that some of the newborn cells in the survival paradigm functionally integrated in NABs, while no such evidence was found in HABs. Gene array studies revealed lower abundance of cyclin-dependent kinase 5 (Cdk5) and brain-derived neurotrophic factor (BDNF) in HABs which might contribute to reduced neurogenesis. Finally, although chronic treatment with fluoxetine reduced the depression-like behavior exclusively in female HABs, it did not alter cell survival or functional integration of newborn neurons in the DG.

Conclusion

Taken together, the enhanced depression-like behavior in a psychopathological animal model is accompanied by decreased hippocampal neurogenesis as well as BDNF and CdK5 expression possibly contributing to the phenotype. Since the antidepressant effect of fluoxetine is discerned from neurogenesis, it is suggested that mechanisms other than adult neurogenesis underlie the therapeutic action of SSRIs in the HAB model, which, however, has to be confirmed by using additional SSRIs. Thus, the present data do not support the idea that neurogenesis is a prerequisite for therapeutic actions common to all antidepressants. Moreover, these findings highlight the importance of psychopathological animal models in order to investigate molecular mechanisms of effective antidepressants.

Declarations

Acknowledgements

Supported by FWF DK SPIN W1206-B05.

Authors’ Affiliations

(1)
Department of Pharmacology and Toxicology, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck
(2)
Max Planck Institute of Psychiatry
(3)
Division of Neuroanatomy, Innsbruck Medical University

Copyright

© Sah et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement